|
RCOR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.990000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.062000E-03 |
| Normal-vs-Stage2 |
4.896000E-03 |
| Normal-vs-Stage3 |
1.436310E-03 |
| Normal-vs-Stage4 |
1.371690E-04 |
| Stage1-vs-Stage2 |
8.299600E-01 |
| Stage1-vs-Stage3 |
6.195800E-01 |
| Stage1-vs-Stage4 |
1.939950E-01 |
| Stage2-vs-Stage3 |
8.840800E-01 |
| Stage2-vs-Stage4 |
3.454800E-01 |
| Stage3-vs-Stage4 |
3.959200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.062000E-03 |
| Normal-vs-AfricanAmerican |
6.122300E-02 |
| Normal-vs-Asian |
8.555800E-03 |
| Caucasian-vs-AfricanAmerican |
7.869600E-01 |
| Caucasian-vs-Asian |
9.849800E-01 |
| AfricanAmerican-vs-Asian |
7.878600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.221500E-03 |
| Normal-vs-Female |
7.154000E-04 |
| Male-vs-Female |
7.800000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.646440E-02 |
| Normal-vs-Age(41-60Yrs) |
1.611930E-04 |
| Normal-vs-Age(61-80Yrs) |
3.395800E-04 |
| Normal-vs-Age(81-100Yrs) |
3.058200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.335800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.799240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.512200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.797400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.281000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.444800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.282600E-01 |
| Classical-VS-Follicular |
5.380000E-04 |
| Classical-VS-Other |
5.244800E-01 |
| Classical-VS-Normal |
1.639580E-02 |
| Tall-VS-Follicular |
1.409220E-01 |
| Tall-VS-Other |
7.882400E-01 |
| Tall-VS-Normal |
3.195500E-02 |
| Follicular-VS-Other |
5.927600E-01 |
| Follicular-VS-Normal |
1.59340000005503E-06 |
| Other-VS-Normal |
9.454100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.96130000000339E-05 |
| Normal-vs-N1 |
1.400470E-03 |
| N0-vs-N1 |
8.782200E-01 |
|
|
